Application 079040
- Type
- ANDA
- Sponsor
- ACTAVIS ELIZABETH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | MORPHINE SULFATE | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | 30MG | No | No |
| 002 | MORPHINE SULFATE | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | 45MG | No | No |
| 003 | MORPHINE SULFATE | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | 60MG | No | No |
| 004 | MORPHINE SULFATE | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | 75MG | No | No |
| 005 | MORPHINE SULFATE | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | 90MG | No | No |
| 006 | MORPHINE SULFATE | MORPHINE SULFATE | CAPSULE, EXTENDED RELEASE;ORAL | 120MG | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079040-001 | MORPHINE SULFATE | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | ||
| A079040-002 | MORPHINE SULFATE | MORPHINE SULFATE | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | ||
| A079040-003 | MORPHINE SULFATE | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | ||
| A079040-004 | MORPHINE SULFATE | MORPHINE SULFATE | 75MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | ||
| A079040-005 | MORPHINE SULFATE | MORPHINE SULFATE | 90MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | ||
| A079040-006 | MORPHINE SULFATE | MORPHINE SULFATE | 120MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 2013-01-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A079040-001 | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A079040-002 | MORPHINE SULFATE | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A079040-003 | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A079040-004 | MORPHINE SULFATE | 75MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A079040-005 | MORPHINE SULFATE | 90MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | c2088c7a36db… | ||
| 2026-10-15 13:18:30 | 2026-09 | A079040-006 | MORPHINE SULFATE | 120MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 2013-01-16 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A079040-001 | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079040-002 | MORPHINE SULFATE | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079040-003 | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079040-004 | MORPHINE SULFATE | 75MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079040-005 | MORPHINE SULFATE | 90MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079040-006 | MORPHINE SULFATE | 120MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 2013-01-16 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A079040-001 | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079040-002 | MORPHINE SULFATE | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079040-003 | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079040-004 | MORPHINE SULFATE | 75MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079040-005 | MORPHINE SULFATE | 90MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079040-006 | MORPHINE SULFATE | 120MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 2013-01-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A079040-001 | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079040-002 | MORPHINE SULFATE | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079040-003 | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079040-004 | MORPHINE SULFATE | 75MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079040-005 | MORPHINE SULFATE | 90MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079040-006 | MORPHINE SULFATE | 120MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 2013-01-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079040-001 | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079040-002 | MORPHINE SULFATE | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079040-003 | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079040-004 | MORPHINE SULFATE | 75MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079040-005 | MORPHINE SULFATE | 90MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079040-006 | MORPHINE SULFATE | 120MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 2013-01-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A079040-001 | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079040-002 | MORPHINE SULFATE | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079040-003 | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079040-004 | MORPHINE SULFATE | 75MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079040-005 | MORPHINE SULFATE | 90MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079040-006 | MORPHINE SULFATE | 120MG | CAPSULE, EXTENDED RELEASE / ORAL | RS | 2013-01-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079040-001 | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079040-002 | MORPHINE SULFATE | 45MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079040-003 | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079040-004 | MORPHINE SULFATE | 75MG | CAPSULE, EXTENDED RELEASE / ORAL | 2013-01-16 | fd3edfee7708… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Morphine sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | 73a39ce5-b2ab-47b9-8860-796f1d5bc8d8 | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | Morphine sulfate MORPHINE SULFATE |
| Morphine sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | ad08cd86-3825-4e77-bbe8-f6333a9ca9d7 | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | Morphine sulfate MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Lupin Pharmaceuticals,Inc. | d360a33f-6323-4b10-9e81-07e2813c2dbd | 2024-02-16 | Boxed warning, Warnings, Adverse reactions | Morphine Sulfate MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | efccad6e-213b-4335-9a4f-3b81322f77c4 | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | Morphine Sulfate MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | f4f9a7cd-fa6c-41cd-8c4b-04626cfa410a | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | Morphine Sulfate MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | 72e2071a-43d6-4480-bb84-4984a976618b | 2024-01-11 | Boxed warning, Warnings, Adverse reactions | Morphine Sulfate MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | 996ac31e-589f-4d5a-84bc-8350e7ea864f | 2024-01-10 | Boxed warning, Warnings, Adverse reactions | Morphine Sulfate MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Padagis US LLC | 649d731b-962a-45df-b043-7e0781e8a530 | 2023-07-01 | Boxed warning, Warnings, Adverse reactions | Morphine Sulfate MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Bryant Ranch Prepack | b7b86b6d-9a39-494c-bf65-f62e4cdc5807 | 2023-03-02 | Boxed warning, Warnings, Adverse reactions | Morphine Sulfate MORPHINE SULFATE |
| Morphine Sulfate | MORPHINE SULFATE | Winder Laboratories LLC | e9a7319a-bf1f-48db-a71e-6d4e6ead9555 | 2022-02-28 | Boxed warning, Warnings, Adverse reactions | Morphine Sulfate MORPHINE SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0228-3090 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3090 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3090 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3090 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3090 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3090 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3091 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3091 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3091 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3091 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3091 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3091 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3092 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3092 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3092 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3092 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3092 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3092 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3093 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3093 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3093 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3093 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3093 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3093 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3116 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3116 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3116 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3116 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3116 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3116 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3117 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3117 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3117 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3117 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3117 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |
| 0228-3117 | Morphine sulfate | Morphine sulfate | Actavis Pharma, Inc. | ANDA | Current |